Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in Ovarian Aging
NCT05836025Phase 2Active, not recruiting
- Sponsor
- Columbia University
- Start
- Jun 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in perimenopause, ovarian aging, sponsored by Columbia University. Started Jun 2023; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
perimenopauseovarian aging
Beyond the preview
Go deeper on NCT05836025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05836025.